ICML 2017: Highlights

Interviewer: Esther Drain

Dr Toby Eyre (Oxford),  Professor Anas Younes (MSKCC, USA), Dr Andrew Davies (Southampton) and Dr Graham Collins (Oxford) discuss new data in CAR T cell therapy and the first EZH2 inhibitor, tazemetostat, in the management of follicular lymphoma as their highlights at ICML.

Professor John Radford (Manchester), Professor Peter Johnson (Southampton) and Professor Stephen Ansell (Mayo Clinic, USA) highlight data from Rathl, emerging data on circulating tumour DNA and a general round up of the meeting.